Skip to main navigation Skip to search Skip to main content

Immunohistochemical evaluation of P‐glycoprotein in human malignancies by monoclonal antibody MC57

  • Eugenio Leonardo
  • , Guido Valente
  • , Susanna Cappia
  • , Maurizio Cianfriglia
  • , Giuseppe Arancia
  • , Stefania Meschini
  • , Giorgio V. Scagliotti

Research output: Contribution to journal › Article › peer-review

Abstract

P‐glycoprotein expression was analyzed on 137 formalinfixed, paraffin‐embedded human tumours by monoclonal antibody (MAb) MC57. This MAb recognizes an extracellular human specific P‐glycoprotein epitope and defines their multidrug resistance (MDR) phenotype by its binding on cells. Immunohistochemistry indicated that this MAb reacted in human cells and tissues in the same pattern as that found with other MAbs to P‐glycoprotein. However, the present extensive study demonstrated that MAb MC57 is a highly specific reagent for the evaluation of an extracellular P‐glycoprotein epitope preserved after fixation procedures and that this MAb is available to assess P‐glycoprotein expression in routinely processed human tumour specimens. © 1994 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)841-846
Number of pages6
JournalInternational Journal of Cancer
Volume57
Issue number6
DOIs
Publication statusPublished - 15 Jun 1994
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Immunohistochemical evaluation of P‐glycoprotein in human malignancies by monoclonal antibody MC57'. Together they form a unique fingerprint.

Cite this